Studies | Antimicrobial | Dosea | Duration | n | Clinical cure | Recurrence | Bacteriological cure | |||
---|---|---|---|---|---|---|---|---|---|---|
n | % | n | % | n | % | |||||
30Gleckman et al 1979 | TMP-SMX+ Placebo | 160/800 mg BD | 14 days | 21 | 13 | 62 | 6 | 29 | ||
TMP-SMX | 160/800 mg BD | 42 days | 21 | 6 | 29 | 13 | 62 | |||
31Iravani 1992 | Lomefloxacin | 400 mg QD | 7–10 days | 10 | 10 | 100 | 10 | 100 | ||
Norfloxacin | 400 mg BD | 7–10 days | 11 | 11 | 100 | 10 | 91 | |||
29van Nieuwkoop et al 2017 | Ciprofloxacin | 500 mg BD | 7 days | 19 | 17 | 90 | 2 | 11 | 19 | 100 |
Ciprofloxacin | 500 mg BD | 14 days | 19 | 19 | 100 | 2 | 11 | 18a | 100 |
BD = twice a day. TMP-SMX = trimethoprim-sulfamethoxazole. QD = once a day. aOne missing urine sample.